Abstract
Chagas disease is a potentially fatal disease caused by the parasite Trypanosoma cruzi, which can in some cases affect the central nervous system. The objective was to evaluate the effect of aspirin (ASA) in the behavior of mice infected with T. cruzi during the acute phase. This was an experimental study with random assignation. Twenty four BALB/c mice were divided into four groups of six animals each as follows: only ASA (OA), ASA before infection (BI), ASA after infection (AI) and only infection (OI). The strain used for infection was M/HOM/Bra/53/Y. An ASA dose of 100 mg/kg per day was administered 72 h before infection to BI group and the same dose 48 h after infection to AI group. Mice behavior in the open field test, mortality, and brain histopathology was evaluated. Data were analyzed using ANOVA, chi square test, and Kaplan-Meier with long-rank for survival analysis. In the open field test, the OA group has similar results with the BI group, in the variables of immobility and escape. Also, the OA group displayed significantly higher rates of micturition (p < 0.001) and defecation (p < 0.001) compared to infected groups. Mortality was higher in BI group (p = 0.02). The presence of T. cruzi amastigotes were higher in brain tissues of the AI and OI groups (p = 0.008). In conclusion, the administration of ASA before infection seemed to prevent behavioral changes induced by the acute infection, but it led to accelerated mortality. The study highlighted the potential importance of the pathways inhibited by ASA in the early hours of acute infection with T. cruzi.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Araki R, Hiraki Y, Nishida S, Inatomi Y, Yabe T (2016) Gomisin N ameliorates lipopolysaccharide-induced depressive-like behaviors by attenuating inflammation in the hypothalamic paraventricular nucleus and central nucleus of the amygdala in mice. J Pharmacol Sci 132(2):138–144. https://doi.org/10.1016/j.jphs.2016.09.004
Ashton AW, Mukherjee S, Nagajyothi F et al (2007) Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J Exp Med 204(4):929–940. https://doi.org/10.1084/jem.20062432
Auriel E, Regev K, Korczyn AD (2014) Nonsteroidal anti-inflammatory drugs exposure and the central nervous system. Handb Clin Neurol 119:577–584. https://doi.org/10.1016/B978-0-7020-4086-3.00038-2
Bae M-K, Kim S-R, Lee H-J, Wee HJ, Yoo MA, Ock Oh S, Baek SY, Kim BS, Kim JB, Sik-Yoon, Bae SK (2006) Aspirin-induced blockade of NF-κB activity restrains up-regulation of glial fibrillary acidic protein in human astroglial cells. Biochim Biophys Acta BBA - Mol Cell Res 1763(3):282–289. https://doi.org/10.1016/j.bbamcr.2006.01.005
Bertolini A, Ottani A, Sandrini M (2002) Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Curr Med Chem 9(10):1033–1043. https://doi.org/10.2174/0929867024606650
Bhatt S, Pundarikakshudu K, Patel P et al (2016a) Beneficial effect of aspirin against interferon-α-2b-induced depressive behavior in Sprague Dawley rats. Clin Exp Pharmacol Physiol 43:1208–1215. https://doi.org/10.1111/1440-1681.12660
Bhatt S, Shukla P, Raval J, Goswami S (2016b) Role of aspirin and dexamethasone against experimentally induced depression in rats. Basic Clin Pharmacol Toxicol 119(1):10–18. https://doi.org/10.1111/bcpt.12539
Bhattacharya P, Pandey AK, Paul S, Patnaik R, Yavagal DR (2013) Aquaporin-4 inhibition mediates piroxicam-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rodents. PLoS One 8(9):e73481. https://doi.org/10.1371/journal.pone.0073481
Boczko J, Tar M, Melman A, Jelicks LA, Wittner M, Factor SM, Zhao D, Hafron J, Weiss LM, Tanowitz HB, Christ GJ (2005) Trypanosoma cruzi infection induced changes in the innervation, structure and function of the murine bladder. J Urol 173(5):1784–1788. https://doi.org/10.1097/01.ju.0000154170.87947.b8
Brinker T, Stopa E, Morrison J, Klinge P (2014) A new look at cerebrospinal fluid circulation. Fluids Barriers CNS 11(1):10. https://doi.org/10.1186/2045-8118-11-10
Bucci DJ, Robinson S (2014) Toward a conceptualization of retrohippocampal contributions to learning and memory. Neurobiol Learn Mem 116:197–207. https://doi.org/10.1016/j.nlm.2014.05.007
Calvello R, Panaro MA, Carbone ML, Cianciulli A, Perrone MG, Vitale P, Malerba P, Scilimati A (2012) Novel selective COX-1 inhibitors suppress neuroinflammatory mediators in LPS-stimulated N13 microglial cells. Pharmacol Res 65(1):137–148. https://doi.org/10.1016/j.phrs.2011.09.009
Caradonna K, PereiraPerrin M (2009) Preferential brain homing following intranasal administration of Trypanosoma cruzi. Infect Immun 77(4):1349–1356. https://doi.org/10.1128/IAI.01434-08
Cardoso MS, Reis-Cunha JL, Bartholomeu DC (2015) Evasion of the immune response by Trypanosoma cruzi during acute infection. Front Immunol 6:659. https://doi.org/10.3389/fimmu.2015.00659
CCAC [Canadian Council on Animal Care] (1993) Guide to the care and use of experimental animals, 2nd edn. Canadian Council on Animal Care, Ottawa, Ontario, Canada
Celentano AM, Gorelik G, Solana ME, Sterin-Borda L, Borda E, González Cappa SM (1995) PGE2 involvement in experimental infection with Trypanosoma cruzi subpopulations. Prostaglandins 49(3):141–153. https://doi.org/10.1016/0090-6980(95)00002-R
Chen Q, Tarr AJ, Liu X et al (2013) Controlled progressive innate immune stimulation regimen prevents the induction of sickness behavior in the open field test. J Inflamm Res 6:91–98. https://doi.org/10.2147/JIR.S45111
Cruz JC, Flôr AFL, França-Silva MS, Balarini CM, Braga VA (2015) Reactive oxygen species in the paraventricular nucleus of the hypothalamus alter sympathetic activity during metabolic syndrome. Front Physiol 6:384. https://doi.org/10.3389/fphys.2015.00384
da Silva AA, Vilar Pereira GV, de Souza AS et al (2010) Trypanosoma cruzi-induced central nervous system alterations: from the entry of inflammatory cells to potential cognitive and psychiatric abnormalities. J Neuro-Oncol 1:1–13. https://doi.org/10.4303/jnp/N100901
de Oliveira GM, de Melo MM, da Silva BW et al (2008) Applicability of the use of charcoal for the evaluation of intestinal motility in a murine model of Trypanosoma cruzi infection. Parasitol Res 102(4):747–750. https://doi.org/10.1007/s00436-007-0829-8
Dillingham CM, Frizzati A, Nelson AJD, Vann SD (2015) How do mammillary body inputs contribute to anterior thalamic function? Neurosci Biobehav Rev 54:108–119. https://doi.org/10.1016/j.neubiorev.2014.07.025
Elkabes S, Peng L, Black IB (1998) Lipopolysaccharide differentially regulates microglial trk receptor and neurotrophin expression. J Neurosci Res 54(1):117–122. https://doi.org/10.1002/(SICI)1097-4547(19981001)54:1<117::AID-JNR12>3.0.CO;2-4
Ennaceur A (2014) Tests of unconditioned anxiety—pitfalls and disappointments. Physiol Behav 135:55–71. https://doi.org/10.1016/j.physbeh.2014.05.032
Feilij H, Muller L, Gonzalez Cappa SM (1983) Direct micromethod for diagnosis of acute and congenital Chagas’ disease. J Clin Microbiol 18(2):327–330
Freire-de-Lima CG, Nascimento DO, Soares MB et al (2000) Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403(6766):199–203. https://doi.org/10.1038/35003208
Harizi H, Norbert G, Hedi H (2004) Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells. Cell Immunol 228(2):99–109. https://doi.org/10.1016/j.cellimm.2004.04.003
Hoff R, Teixeira RS, Carvalho JS, Mott KE (1978) Trypanosoma cruzi in the cerebrospinal fluid during the acute stage of Chagas’ disease. N Engl J Med 298(11):604–606. https://doi.org/10.1056/NEJM197803162981106
Holscher C, Mohrs M, Dai WJ, Kohler G, Ryffel B, Schaub GA, Mossmann H, Brombacher F (2000) Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect Immun 68(7):4075–4083. https://doi.org/10.1128/IAI.68.7.4075-4083.2000
Junior CFC, Pederiva CN, Bose RC et al (2012) ETHOWATCHER: validation of a tool for behavioral and video-tracking analysis in laboratory animals. Comput Biol Med 42(2):257–264. https://doi.org/10.1016/j.compbiomed.2011.12.002
Karmarkar SW, Bottum KM, Tischkau SA (2010) Considerations for the use of anesthetics in neurotoxicity studies. Comp Med 60(4):256–262
Kirkby NS, Zaiss AK, Wright WR, Jiao J, Chan MV, Warner TD, R. Herschman H, Mitchell JA (2013) Differential COX-2 induction by viral and bacterial PAMPs: consequences for cytokine and interferon responses and implications for anti-viral COX-2 directed therapies. Biochem Biophys Res Commun 438(2):249–256. https://doi.org/10.1016/j.bbrc.2013.07.006
Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ, Chen L, Chen L, Chen TM, Chi Chin M, Chong J, Crook BE, Czaplinska A, Dang CN, Datta S, Dee NR, Desaki AL, Desta T, Diep E, Dolbeare TA, Donelan MJ, Dong HW, Dougherty JG, Duncan BJ, Ebbert AJ, Eichele G, Estin LK, Faber C, Facer BA, Fields R, Fischer SR, Fliss TP, Frensley C, Gates SN, Glattfelder KJ, Halverson KR, Hart MR, Hohmann JG, Howell MP, Jeung DP, Johnson RA, Karr PT, Kawal R, Kidney JM, Knapik RH, Kuan CL, Lake JH, Laramee AR, Larsen KD, Lau C, Lemon TA, Liang AJ, Liu Y, Luong LT, Michaels J, Morgan JJ, Morgan RJ, Mortrud MT, Mosqueda NF, Ng LL, Ng R, Orta GJ, Overly CC, Pak TH, Parry SE, Pathak SD, Pearson OC, Puchalski RB, Riley ZL, Rockett HR, Rowland SA, Royall JJ, Ruiz MJ, Sarno NR, Schaffnit K, Shapovalova NV, Sivisay T, Slaughterbeck CR, Smith SC, Smith KA, Smith BI, Sodt AJ, Stewart NN, Stumpf KR, Sunkin SM, Sutram M, Tam A, Teemer CD, Thaller C, Thompson CL, Varnam LR, Visel A, Whitlock RM, Wohnoutka PE, Wolkey CK, Wong VY, Wood M, Yaylaoglu MB, Young RC, Youngstrom BL, Feng Yuan X, Zhang B, Zwingman TA, Jones AR (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature 445(7124):168–176. https://doi.org/10.1038/nature05453
Luo J, Wang T, Liang S, Hu X, Li W, Jin F (2013) Experimental gastritis leads to anxiety- and depression-like behaviors in female but not male rats. Behav Brain Funct BBF 9(1):46. https://doi.org/10.1186/1744-9081-9-46
Machado FS, Dutra WO, Esper L, Gollob KJ, Teixeira MM, Factor SM, Weiss LM, Nagajyothi F, Tanowitz HB, Garg NJ (2012) Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease. Semin Immunopathol 34(6):753–770. https://doi.org/10.1007/s00281-012-0351-7
Machado FS, Mukherjee S, Weiss LM et al (2011) Bioactive lipids in Trypanosoma cruzi infection. Adv Parasitol 76:1–31. https://doi.org/10.1016/B978-0-12-385895-5.00001-3
Masocha W, Kristensson K (2012) Passage of parasites across the blood-brain barrier. Virulence 3(2):202–212. https://doi.org/10.4161/viru.19178
Michelin MA, Silva JS, Cunha FQC (2005) Inducible cyclooxygenase released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection. Exp Parasitol 111(2):71–79. https://doi.org/10.1016/j.exppara.2005.05.001
Milner LC, Crabbe JC (2008) Three murine anxiety models: results from multiple inbred strain comparisons. Genes Brain Behav 7(4):496–505. https://doi.org/10.1111/j.1601-183X.2007.00385.x
Molina-Berríos A, Campos-Estrada C, Henriquez N, Faúndez M, Torres G, Castillo C, Escanilla S, Kemmerling U, Morello A, López-Muñoz RA, Maya JD (2013a) Protective role of acetylsalicylic acid in experimental Trypanosoma cruzi infection: evidence of a 15-epi-Lipoxin A4-mediated effect. PLoS Negl Trop Dis 7(4):e2173. https://doi.org/10.1371/journal.pntd.0002173
Molina-Berríos A, Campos-Estrada C, Lapier M, Duaso J, Kemmerling U, Galanti N, Ferreira J, Morello A, López-Muñoz R, Maya JD (2013b) Protection of vascular endothelium by aspirin in a murine model of chronic Chagas’ disease. Parasitol Res 112(7):2731–2739. https://doi.org/10.1007/s00436-013-3444-x
Moraes KC, Diniz LF, Bahia MT (2015) Role of cyclooxygenase-2 in Trypanosoma cruzi survival in the early stages of parasite host-cell interaction. Mem Inst Oswaldo Cruz 110(2):181–191. https://doi.org/10.1590/0074-02760140311
Moreira NM, Sant’ana DMG, Araújo EJA et al (2011) Neuronal changes caused by Trypanosoma cruzi: an experimental model. An Acad Bras Ciênc 83(2):545–555. https://doi.org/10.1590/S0001-37652011000200014
Morocoima A, Socorro G, Avila R et al (2012) Trypanosoma cruzi: experimental parasitism in the central nervous system of albino mice. Parasitol Res 111(5):2099–2107. https://doi.org/10.1007/s00436-012-3057-9
Mukherjee S, Machado FS, Huang H, Oz HS, Jelicks LA, Prado CM, Koba W, Fine EJ, Zhao D, Factor SM, Collado JE, Weiss LM, Tanowitz HB, Ashton AW (2011) Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease. PLoS One 6(2):e16959. https://doi.org/10.1371/journal.pone.0016959
Nisimura LM, Estato V, de SEM et al (2014) Acute Chagas disease induces cerebral microvasculopathy in mice. PLoS Negl Trop Dis 8(7):e2998. https://doi.org/10.1371/journal.pntd.0002998
Paiva CN, Arras RH, Lessa LP, Gibaldi D, Alves L, Metz CN, Gazzinelli R, Pyrrho AS, Lannes-Vieira J, Bozza MT (2007) Unraveling the lethal synergism between Trypanosoma cruzi infection and LPS: a role for increased macrophage reactivity. Eur J Immunol 37(5):1355–1364. https://doi.org/10.1002/eji.200636705
Pinge-Filho P, Tadokoro CE, Abrahamsohn IA (1999) Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cell Immunol 193(1):90–98. https://doi.org/10.1006/cimm.1999.1463
Pinto AMT, Sales PCM, Camargos ERS, Silva AM (2011) Tumour necrosis factor (TNF)-mediated NF-κB activation facilitates cellular invasion of non-professional phagocytic epithelial cell lines by Trypanosoma cruzi. Cell Microbiol 13(10):1518–1529. https://doi.org/10.1111/j.1462-5822.2011.01636.x
Previch LE, Ma L, Wright JC et al (2016) Progress in AQP research and new developments in therapeutic approaches to ischemic and hemorrhagic stroke. Int J Mol Sci 17(7). https://doi.org/10.3390/ijms17071146
Py MO (2011) Neurologic manifestations of Chagas disease. Curr Neurol Neurosci Rep 11(6):536–542. https://doi.org/10.1007/s11910-011-0225-8
Quan N, Mhlanga JD, Whiteside MB et al (2000) Chronic sodium salicylate treatment exacerbates brain neurodegeneration in rats infected with Trypanosoma brucei. Neuroscience 96(1):181–194. https://doi.org/10.1016/S0306-4522(99)00492-3
Rachid MA, Teixeira AL, Barcelos LS, Machado CRS, Chiari E, Tanowitz HB, Camargos ERS, Teixeira MM (2010) Role of endothelin receptors in the control of central nervous system parasitism in Trypanosoma cruzi infection in rats. J Neuroimmunol 220(1-2):64–68. https://doi.org/10.1016/j.jneuroim.2010.01.008
Ramos A, Mormède P (1998) Stress and emotionality: a multidimensional and genetic approach. Neurosci Biobehav Rev 22(1):33–57
Rauschka H, Aboul-Enein F, Bauer J, Nobis H, Lassmann H, Schmidbauer M (2007) Acute cerebral white matter damage in lethal salicylate intoxication. Neurotoxicology 28(1):33–37. https://doi.org/10.1016/j.neuro.2006.06.010
Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22(3):659–661. https://doi.org/10.1096/fj.07-9574LSF
Roelofs S, Boleij H, Nordquist RE, van der Staay FJ (2016) Making decisions under ambiguity: judgment bias tasks for assessing emotional state in animals. Front Behav Neurosci 10:119. https://doi.org/10.3389/fnbeh.2016.00119
Rossi MA, Tanowitz HB, Malvestio LM, Celes MR, Campos EC, Blefari V, Prado CM (2010) Coronary microvascular disease in chronic Chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms. PLoS Negl Trop Dis 4(8):e674. https://doi.org/10.1371/journal.pntd.0000674
Salim S, Chugh G, Asghar M (2012) Inflammation in anxiety. Adv Protein Chem Struct Biol 88:1–25. https://doi.org/10.1016/B978-0-12-398314-5.00001-5
Silva RR, Mariante RM, Silva AA, dos Santos ALB, Roffê E, Santiago H, Gazzinelli RT, Lannes-Vieira J (2015) Interferon-gamma promotes infection of astrocytes by Trypanosoma cruzi. PLoS One 10(2):e0118600. https://doi.org/10.1371/journal.pone.0118600
Tarr AJ, Chen Q, Wang Y, Sheridan JF, Quan N (2012) Neural and behavioral responses to low-grade inflammation. Behav Brain Res 235(2):334–341. https://doi.org/10.1016/j.bbr.2012.07.038
Tatakihara VLH, Cecchini R, Borges CL et al (2008) Effects of cyclooxygenase inhibitors on parasite burden, anemia and oxidative stress in murine Trypanosoma cruzi infection. FEMS Immunol Med Microbiol 52(1):47–58. https://doi.org/10.1111/j.1574-695X.2007.00340.x
Vargas-Zambrano JC, Lasso P, Cuellar A, Puerta CJ, González JM (2013) A human astrocytoma cell line is highly susceptible to infection with Trypanosoma cruzi. Mem Inst Oswaldo Cruz 108(2):212–219. https://doi.org/10.1590/0074-0276108022013014
Vilar-Pereira G, da Silva AA, Pereira IR et al (2012) Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions. Brain Behav Immun 26(7):1136–1149. https://doi.org/10.1016/j.bbi.2012.07.009
Weinkauf C, Salvador R, PereiraPerrin M (2011) Neurotrophin receptor TrkC is an entry receptor for Trypanosoma cruzi in neural, glial, and epithelial cells. Infect Immun 79(10):4081–4087. https://doi.org/10.1128/IAI.05403-11
Acknowledgments
To the Department of Tropical Medicine of the IICS for the support in infrastructure and materials. Special thanks to Marisel Maldonado and Michael Lewis for his suggestions and assistance in the article.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Online Resource 1
Study design. Diagram of groups distribution, infection and administration of ASA. The dose of ASA varied between 90 and 100 mg/kg/day and for the infection 5 × 104 parasites of Y (epsilon) strain were inoculated intraperitoneally. (GIF 32 kb)
Rights and permissions
About this article
Cite this article
Silvero-Isidre, A., Morínigo-Guayuán, S., Meza-Ojeda, A. et al. Protective effect of aspirin treatment on mouse behavior in the acute phase of experimental infection with Trypanosoma cruzi . Parasitol Res 117, 189–200 (2018). https://doi.org/10.1007/s00436-017-5693-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-017-5693-6